FitLife Brands, Inc. is a provider of nutritional supplements and wellness products for health-conscious consumers. The company operates through five main product groups: NDS Products, iSatori Products, MRC Products, MusclePharm, and Irwin Products. NDS Products, including brands such as NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, and Metis Nutrition, are distributed principally through franchised General Nutrition Centers (GNC) stores in the United States and internationally. iSatori Products, comprising iSatori, BioGenetic Laboratories, and Energize, are sold through specialty and mass market retailers as well as online. MRC Products, which include Dr. Tobias, All Natural Advice, and Maritime Naturals, are distributed primarily via e-commerce platforms like Amazon. MusclePharm products are sold to wholesale customers and directly to consumers online. Irwin Products, acquired in 2025, include Irwin Naturals, Applied Nutrition, and Nature’s Secret, and are sold through mass market retailers such as CVS, Walmart, Walgreens, and Costco Canada, as well as online. The company’s products focus on sports nutrition, weight loss, general health, energy, and skincare, manufactured by FDA-regulated contract manufacturers in the United States.

Summarised from the company's own disclosures, fiscal year ended Mar 2026

Industry Packaged Foods Homepage fitlifebrands.com
Sector Consumer Defensive IR page fitlifebrands.com/pages/investors
Tags
nutritional supplements, sports nutrition, weight loss, general health, energy products, skincare, beauty products, contract manufacturing, e-commerce, wholesale distribution, NDS Nutrition, PMD Sports, SirenLabs, Core Active, Nutrology, Metis Nutrition, iSatori, BioGenetic Laboratories, Energize, Dr. Tobias, All Natural Advice, Maritime Naturals, MusclePharm, Irwin Naturals, Applied Nutrition, Nature’s Secret, General Nutrition Centers, GNC, Amazon, CVS, Walmart, Walgreens, Costco Canada
Press page —

Metrics

Valuation  
Market cap $ 87.336M
Market cap (USD) $ 87.336M
P/E 13.48
PEG 1.07
P/BV 1.77
P/S 0.84
P/OCF 18.63
P/FCF 18.65
Dividend yield —
Turnover / mcap —
Returns  
ROE 15.9%
ROI 7.2%
ROIC 8.8%
Profit margin 7.8%
Growth  
Revenue growing Yes
Profits growing No
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 12.6%
Quality  
Profitable Yes
Margin expanding No
Buying back stock No
Diluting (TTM) No
Debt/Equity 102.1%
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 1
Quality score 22.2%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007
Revenue 81.458M 64.469M 52.7M 28.803M 27.913M 21.744M 19.497M 17.077M 17.799M 25.314M 17.931M 19.96M 19.684M 18.093M 12.092M 8.148M 8.735M 2.53M —
Net profit 6.326M 8.984M 5.296M 4.429M 5.41M 8.714M 2.698M 509K -9.762M 368.078K -1.166M 1.674M 1.292M 2.524M 326.652K -3.178M -10.783M -6.626M -3.962M
Free cash flow 7.397M 9.6M 4.114M 4.13M 4.48M — — 258K 480.717K -111.821K -2.468M 1.503M — — 102.785K -1.868M -1.583M -4.929M -1.414M

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007
Share price 16.27 32.6 19.1 — 28.5 13.5 8.73 0.36 — — 1.8 2.6 2 — — — — — —
Price performance 12m -0.5 0.71 — — 1.11 0.55 23.25 — — — -0.31 0.3 — — — — — — —

Filed figures

Figure Dec 2016 Dec 2017 Dec 2018 Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (USD) 2.79M 1.96M 1.43M 2.37M 2.04M 945,000 705,000 2.05M 1.63M 8.77M
↳ YoY growth +4.0% -29.9% -26.8% +65.1% -13.6% -53.8% -25.4% +190.2% -20.5% +439.1%
↳ 5y CAGR +21.8% +15.1% +2.6% +7.0% -5.3% -19.5% -18.5% +7.4% -7.2% +33.8%
Borrowings, current (USD) 544,825 414,877 0.00 — — — 0.00 — 4.5M —
Borrowings, non-current (USD) 369,177 0.00 — — — — 0.00 15.5M 8.55M —
Lease liabilities (USD) — — 0.00 254,000 208,000 158,000 103,000 138,000 412,000 705,000
Cash and deposits (USD) 1.29M 1.26M 259,000 265,000 6.34M — — — — —
Intangible assets (USD) 6.51M 225,000 — — 0.00 192,000 150,000 26.3M 26.2M 51.4M
Right-of-use assets (USD) — — 0.00 254,000 208,000 158,000 103,000 121,000 412,000 682,000
Net debt (borrowings + leases - cash) (USD) -379,039 -847,056 -259,000 — — — — — — —
Cash flow detail
Operating cash flow (USD) -88,416 665,781 258,000 2.26M 5.72M 4.48M 4.13M 4.22M 9.61M 7.44M
Purchases of property, plant and equipment (USD) -23,405 -185,064 0.00 — — — 0.00 -106,000 -10,000 -42,000
Change in receivables (cash effect) (USD) 108,082 429,153 -1.33M -505,000 297,000 974,000 247,000 -882,000 361,000 210,000
Change in inventories (cash effect) (USD) -1.03M -972,944 707,000 502,000 -329,000 -2.95M -2.64M 1.03M -2.11M -582,000
Change in payables (cash effect) (USD) -1.77M 1.38M -346,000 -618,000 1.24M -366,000 115,000 -2.68M 866,000 743,000
Dividends paid (cash effect) (USD) — — 0.00 -63,000 0.00 — — — — —
Share buybacks (cash effect) (USD) -44,413 0.00 0.00 -1.52M -171,000 -444,000 -779,000 0.00 — —
Interest paid (cash effect) (USD) -109,391 -112,128 -133,000 -47,000 -12,000 0.00 0.00 -777,000 -1.36M -1.75M
Income taxes paid (cash effect) (USD) — — — — 0.00 42,000 -3,000 -698,000 -2.5M -2.36M
Share-based compensation (USD) — — 130,000 118,000 29,000 100,000 76,000 — — —
Operating cash flow before change in receivables (USD) -196,498 236,628 1.59M 2.77M 5.42M 3.51M 3.88M 5.1M 9.25M 7.23M
Free cash flow (OCF - PPE - intangibles) (USD) -111,821 480,717 258,000 — — — 4.13M 4.11M 9.6M 7.4M
Income detail
Total comprehensive income (USD) — — — — — — 4.43M 5M 8.61M 6.43M
Comprehensive income to owners (USD) — — — — — — 4.43M 5M 8.61M 6.43M
Provision for credit losses (USD) 3,552 169,188 445,000 27,000 51,000 4,000 -6,000 -33,000 24,000 -32,000
Credit cost ratio (credit losses / average receivables) (%) 0.1% 7.1% 26.2% 1.4% 2.3% 0.3% 0.7% 2.4% 1.3% 0.6%
Reported Apr 17, 2017 Apr 17, 2018 Mar 30, 2020 Mar 30, 2020 Oct 13, 2022 Mar 24, 2023 Mar 29, 2024 Mar 29, 2024 Nov 13, 2025 Mar 31, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

FitLife Brands Announces Third Quarter 2026 Results Bull 2 Bear 3 Results

OMAHA, NE – November 16, 2026 – FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the third quarter ended September 30, 2026.

Highlights for the third quarter ended September 30, 2026 include:

• Total revenue was $25.6 million, an increase of 9% compared to the third quarter of 2025, driven by the acquisition of Irwin Naturals, partially offset by lower revenue from Legacy FitLife.

• Wholesale revenue was $13.8 million, representing 54% of total revenue and an increase of 5% compared to the third quarter of 2025.

• Net income for the third quarter of 2026 was $1.6 million compared to $0.9 million during the same period last year, an increase of 71%, driven by the non-recurrence of merger and acquisition related expense associated with the acquisition of Irwin Naturals during the third quarter of 2025 as well as a lower effective tax rate during the third quarter of 2026, partially offset by a restructuring charge during the third quarter of 2026.

FitLife Brands, Inc. — Regulation FD Disclosure Bull 0 Bear 0 Routine

On September 9, 2026, FitLife Brands, Inc. began utilizing a new corporate presentation (the “Corporate Presentation”) for business purposes. A copy of the Corporate Presentation is attached to this Current Report on Form 8-K as Exhibit 99.1.

FitLife Brands Announces Second Quarter 2026 Results Bull 3 Bear 3 Results

OMAHA, NE – August 13, 2026 – FitLife Brands, Inc. (“FitLife” or the “Company”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial results for the second quarter ended June 30, 2026.

Highlights for the second quarter ended June 30, 2026 include:

• Total revenue was $26.5 million, an increase of 65% compared to the second quarter of 2025, driven by the acquisition of Irwin Naturals.

• Wholesale revenue was $14.6 million, representing 55% of total revenue and an increase of 156% compared to the second quarter of 2025.

• Compared to the first quarter of 2026, total revenue increased 4.8% sequentially, with wholesale revenue increasing 3.7% and online revenue increasing 6.3%.

• Net income for the second quarter of 2026 was $2.0 million compared to $1.7 million during the same period last year, an increase of 12%, driven primarily by the acquisition of Irwin Naturals, partially offset by lower gross profit from Legacy FitLife.

• Basic earnings per share and diluted earnings per share were $0.21 and $0.20, respectively, compared to $0.19 and $0.18 for the second quarter of 2025.

Prompts

FitLife Brands, Inc. (ticker FTLF), listed in United States.

Company History

Date Change Detail
Aug 13, 2015 Acquired Acquired Isatori, Inc. (CIK 741114). Its filings from before the deal are on its own company page, not shown here.
Oct 8, 2013 Renamed BOND LABORATORIES, INC. → FITLIFE BRANDS, INC.

ETFs Holding FitLife Brands, Inc.

ETF Weight in ETF Shares Market value As of
IVSS 0.01% 299 $ 3,291.99 Jun 30, 2026
DFUS 0.00% 1,200 $ 9,960.00 Nov 12, 2026